Neurocrine Biosciences (NBIX) Net Equity Issued and Repurchased (2010 - 2026)
Neurocrine Biosciences (NBIX) reported Net Equity Issued and Repurchased of $84.8 million for Q2 2026, up 488.9% from $14.4 million a year earlier and up 259.3% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Neurocrine Biosciences' Net Equity Issued and Repurchased came in at $191.3 million, up 130.8% year-over-year; for FY2025, it was $129.4 million, up 6.0% from FY2024.
- Net Equity Issued and Repurchased has increased for four consecutive years, with a five-year compound annual growth rate of 34.8% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $122.1 million in FY2024 (+87.0%), $65.3 million in FY2023 (+46.1%), $44.7 million in FY2022 (+62.5%) and $27.5 million in FY2021 (-5.5%).
- The Q2 2026 figure ranks as the highest quarterly Net Equity Issued and Repurchased since Q1 2015.
- Year over year, Net Equity Issued and Repurchased gained in four of the last eight quarters, with growth averaging 89.2%.
- The high point for year-over-year Net Equity Issued and Repurchased in five years was Q1 2024 (growth of 752.4%); the low point was Q4 2024 (a decline of 71.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $23.6 million (Q1 2026), $37.3 million (Q4 2025) and $45.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 84.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84.80 Mn |
| Mar 31, 2026 | 23.60 Mn |
| Dec 31, 2025 | 37.30 Mn |
| Sep 30, 2025 | 45.60 Mn |
| Jun 30, 2025 | 14.40 Mn |
| Mar 31, 2025 | 32.10 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Sep 30, 2024 | 26.40 Mn |
| Jun 30, 2024 | 15.80 Mn |
| Mar 31, 2024 | 69.90 Mn |
| Dec 31, 2023 | 35.40 Mn |
| Sep 30, 2023 | 18.80 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 8.20 Mn |
| Dec 31, 2022 | 24.60 Mn |
| Sep 30, 2022 | 11.40 Mn |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 6.10 Mn |
| Dec 31, 2021 | 1.80 Mn |
| Sep 30, 2021 | 7.50 Mn |
API Access
Neurocrine Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();